We are at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting in Toronto, Canada, through this weekend! We are thrilled to connect with colleagues, peers, and partners to discuss the many unmet needs in bone and mineralization diseases. If you are attending, stop by our booth to learn more about our work to develop potential treatments for #ENPP1 and #ABCC6 Deficiencies. #ASBMR2024 #RareDiseases
Dream team
💚
Amazing Katie! & the team.
Chief Operating Officer (COO) at Inozyme Pharma | >15 years of leadership experience in biotech/pharma industry | Passionate about developing and commercializing innovative therapies for rare and hard to treat diseases
1moGood looking team!